PURPOSE: Recent studies have shown that abnormal distribution of pelvic nerves contributes to endometriosis-associated pain. However, the relationship between neurogenesis and pain severity in endometriosis still remains uncertain, which ma…
Objective:To investigate the diagnostic value of serum tumor markers carbohydrate antigen(CA125)in patients with adenomyosis.Methods:A total of 90 patients with adenomyosis and 68 healthy subjects were chosen.Serum CA125 in 2 groups was det…
Objective To evaluate the quality of life(QOL)and its influencing factors in adenomyosis-associated dysmenorrhea patients.Methods Seventy-three adenomyosis-associated dysmenorrhea patients were chosen as the case group and 90healthy women a…
Objective:The present study used the SF-36 scale to evaluate the quality of life in patients with adenomyosis dysmenorrhea by taking YiKunNeiYi pills treatment.Methods:The present study was a randomized,open-label,non-blinded clinical study…
Objective:To observe the effect of QuYiKang on TXB2 and 6-Keto-PGF1αof endometriosis in rats and to study the possible therapeutic mechanism. Methods: Models of endometriosis in rats were established by operation transportation, which were …
AIM: To study the pathogenesis of endometriosis(EM) by investigating cytokine(CK) and CKR genes expression involved in the development of EM. METHODS: The CK and CKR gene expression pattern in samples of EM and normal endometrial tissues we…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…
The expression of mRNA of Epo and VEGF in endometriosis was 3.08+-0.48 and 2.95+-0.43, respectively, which was significantly higher than those in normal endometrium (P<0.001). The expression of Epo mRNA was closely correlated with that of V…